๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Changes in the fucose content of haptoglobin in breast and ovarian cancer: Association with disease progression

โœ Scribed by E. Dargan; S. Thompson; B. M. J. Cantwell; R. G. Wilson; G. A. Turner

Publisher
Springer US
Year
1994
Tongue
English
Weight
659 KB
Volume
1
Category
Article
ISSN
1573-4986

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cytokeratin expression in breast cancer:
Cytokeratin expression in breast cancer: Phenotypic changes associated with disease progression
โœ I. Brotherick; C. N. Robson; D. A. Browell; J. Shenfine; M. D. White; W. J. Cunl ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 2 views

Transition from a normal to a cancerous state is marked by alterations in the cytoskeletal structure of those cells involved. We have examined such changes to determine if these transitions are markers of disease progression. Cytokeratin (CK) protein and messenger RNA (mRNA) expression were examined

Autonomy of the epithelial phenotype in
Autonomy of the epithelial phenotype in human ovarian surface epithelium: Changes with neoplastic progression and with a family history of ovarian cancer
โœ Helen G. Dyck; Thomas C. Hamilton; Andrew K. Godwin; Henry T. Lynch; Sarah Maine ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 949 KB

Epithelial ovarian carcinomas originate in the ovarian surface epithelium (OSE). In culture, OSE undergoes epithelio-mesenchymal conversion, an event mimicking a wound response, while ovarian carcinomas retain complex epithelial characteristics. To define the onset of this increased epithelial auton

Localization of nuclear cathepsin L and
Localization of nuclear cathepsin L and its association with disease progression and poor outcome in colorectal cancer
โœ Shane Sullivan; Miriam Tosetto; David Kevans; Alan Coss; Laimun Wang; Diarmuid O ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 411 KB ๐Ÿ‘ 1 views

## Abstract Previous __in vitro__ studies have identified a nuclear isoform of Cathepsin L. The aim of this study was to examine if nuclear Cathepsin L exists __in vivo__ and examine its association with clinical, pathological and patient outcome data. Cellular localization (nuclear and cytoplasmic